News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,290 Results
Type
Article (14738)
Company Profile (115)
Press Release (361432)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (112782)
Career Advice (457)
Deals (18655)
Drug Delivery (41)
Drug Development (31257)
Employer Resources (51)
FDA (8837)
Job Trends (7696)
News (173037)
Policy (12397)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1332)
Accelerated approval (10)
Allergies (71)
Alliances (34933)
ALS (42)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (179)
Approvals (9041)
Artificial intelligence (444)
Autoimmune disease (61)
Automation (31)
Bankruptcy (131)
Best Places to Work (6520)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (262)
Cancer (2189)
Cardiovascular disease (149)
Career advice (416)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (489)
Cervical cancer (21)
Clinical research (25870)
Collaboration (1231)
Compensation (230)
Complete response letters (8)
COVID-19 (1223)
CRISPR (85)
C-suite (481)
Cystic fibrosis (60)
Data (2637)
Decentralized trials (1)
Denatured (26)
Depression (43)
Diabetes (211)
Diagnostics (5145)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (163)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (86)
Earnings (40524)
Editorial (9)
Employer branding (8)
Employer resources (45)
Events (53410)
Executive appointments (549)
FDA (10441)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (897)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (302)
Government (1278)
Grass and pollen (3)
Guidances (220)
Healthcare (9917)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1364)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (151)
Interviews (52)
IPO (8060)
IRA (10)
Job creations (1438)
Job search strategy (363)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (131)
Leadership (7)
Legal (2534)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (171)
Machine learning (34)
Management (18)
Manufacturing (524)
MASH (36)
Medical device (11842)
Medtech (11891)
Mergers & acquisitions (11229)
Metabolic disorders (399)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (120)
Neuropsychiatric disorders (19)
Neuroscience (1082)
NextGen: Class of 2026 (3537)
Non-profit (1533)
Now hiring (15)
Obesity (139)
Opinion (97)
Ovarian cancer (92)
Pain (105)
Pancreatic cancer (101)
Parkinson's disease (118)
Partnered (20)
Patents (301)
Patient recruitment (243)
Peanut (31)
People (33675)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase 1 (9519)
Phase 2 (11616)
Phase 3 (7552)
Pipeline (2546)
Policy (59)
Postmarket research (502)
Preclinical (4282)
Press Release (66)
Prostate cancer (96)
Psychedelics (6)
Radiopharmaceuticals (177)
Rare diseases (299)
Real estate (3398)
Recruiting (22)
Regulatory (10374)
Reports (20)
Research institute (1300)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (162)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2528)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (496)
Venture capital (43)
Weight loss (49)
Women's health (45)
Worklife (2)
Date
Last 7 days (274)
Last 30 days (1011)
Last 365 days (14643)
2026 (1396)
2025 (15031)
2024 (18706)
2023 (22097)
2022 (30813)
2021 (32512)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24891)
Australia (4315)
California (5290)
Canada (1668)
China (547)
Colorado (284)
Connecticut (235)
Delaware (107)
Europe (50934)
Florida (906)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (471)
India (33)
Indiana (263)
Iowa (8)
Japan (271)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (718)
Massachusetts (3540)
Michigan (274)
Minnesota (407)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1561)
New Mexico (18)
New York (1418)
North Carolina (758)
North Dakota (9)
Northern California (2241)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1010)
Puerto Rico (19)
Rhode Island (34)
South America (512)
South Carolina (60)
South Dakota (1)
Southern California (2267)
Tennessee (103)
Texas (876)
United States (19712)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (502)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
376,290 Results for "tikcro technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Tikcro Technologies Announces Liquidating Dividend - February 09, 2023
Tikcro Technologies Ltd. announced the declaration of a liquidating cash dividend in the aggregate amount of $3,017,270, or $0.305 per share, without interest and subject to applicable withholding requirements.
February 9, 2023
·
2 min read
Tikcro Technologies Announces Extension of Submission Deadline regarding Liquidating Dividend
Tikcro Technologies Ltd. announced the extension of the deadline for the submission of documentation with respect to exemption from Israeli withholding in connection with its liquidating dividend, from April 10, 2023 to April 28, 2023, in order to enable additional shareholders to perfect exemptions prior to the dividend payment.
April 3, 2023
·
2 min read
Interim Report of Liquidation Trustee of Tikcro Technologies
Tikcro Technologies Ltd. (in liquidation) (OTC: TIKRF) today announced that the liquidation trustee has substantially completed the process of winding down the affairs of the Company.
July 25, 2022
·
1 min read
Tikcro Technologies to Proceed to Distribute Net Cash to Shareholders
Tikcro Technologies Ltd. (OTC: TIKRF) today announced that its Board of Directors has decided to take steps required to distribute the company’s net cash to its shareholders.
March 22, 2021
·
2 min read
Business
Tikcro Technologies Reports Third Quarter 2020 Results
Tikcro Technologies Ltd. (OTCQB: TIKRF), today reported its financial results for the third quarter ended September 30, 2020 . “We continue to consider businesses for a reverse merger and other corporate alternatives,” said Aviv Boim , CEO of Tikcro. Financial Results for the Third Quarter Ended September 30, 2020 N
January 14, 2021
·
2 min read
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Business
Tikcro Technologies Reports Second Quarter 2020 Results
Tikcro Technologies Ltd. (OTCQB: TIKRF) today reported its financial results for the second quarter ended June 30, 2020.
October 30, 2020
·
2 min read
Tikcro Technologies Announces Extraordinary General Meeting - Mar 29, 2021
Tikcro Technologies Ltd. announced that an Extraordinary General Meeting of Shareholders will be held on Thursday, April 29, 2021 at 9:30 a.m., at the office of Goldfarb Seligman & Co., 98 Yigal Alon Street, Tel Aviv, Israel.
March 29, 2021
·
1 min read
Press Releases
Zelluna promotes Emilie Gauthy to Chief Technology Officer
February 3, 2026
·
2 min read
Tikcro Technologies Announces 2020 Annual General Meeting
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its 2020 Annual General Meeting of Shareholders will be held on Thursday, December 31, 2020 at 9:00 a.m. (Israel time), at the office of Goldfarb Seligman & Co., 98 Yigal Alon Street, Tel Aviv, Israel.
November 25, 2020
·
1 min read
1 of 37,629
Next
